Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (NASDAQ: ACLS) has launched its new Purion Power Series+™ ion implant platform, designed for next-generation power devices and superjunction architectures. The platform includes multiple product extensions: Purion H200+ SiC for high current medium energy, Purion M+ SiC for medium current, and Purion XE+ SiC and Purion EXE+ SiC for high energy applications.

The innovative platform offers flexibility to handle multiple wafer sizes (150mm and 200mm), various substrate types (SiC, Si, GaN, GaAs), and different implant temperatures while delivering industry-leading throughput and capital efficiency. This launch reinforces Axcelis' position as the innovation and market leader in ion implantation solutions for power devices.

Axcelis Technologies (NASDAQ: ACLS) has launched its new GSD Ovation™ ES high current ion implanter, specifically designed for engineered substrates. The system represents an evolution of the GSD Ovation Series platform and delivers enhanced capabilities for high current Hydrogen & Helium implant applications, including wafer splitting.

The new system offers superior flexibility and capital efficiency, featuring production-proven wafer handling capability for multiple substrate types including SiC, LiTaO3, and LiNbO3. Notable features include superior beam power, advanced wafer cooling capability, and compatibility with various substrate thicknesses and weights. The system is currently available with factory demo capabilities.

Axcelis Technologies (NASDAQ:ACLS), a leading ion implantation solutions provider for the semiconductor industry, participated in the KORUS Business Roundtable on August 25, 2025, in Washington D.C. The event featured U.S. Secretary of Commerce Howard W. Lutnick and South Korean President Lee Jae Myung, focusing on advancing collaboration, investment, and innovation between the two countries.

Axcelis President and CEO Russell Low emphasized the company's commitment to strengthening international partnerships and their role in delivering high-quality products efficiently. The company aims to build upon its existing relationships with Korean customers and partners amid increased semiconductor industry investments.

Axcelis Technologies (NASDAQ: ACLS), a leading provider of ion implantation solutions for the semiconductor industry, has announced its participation in three upcoming investor conferences in September 2025.

The company will attend the Benchmark Tech, Media & Telecom Conference on September 4th at the New York Athletic Club, the Citi Global TMT Conference on September 5th at the New York Hilton Midtown, and the B. Riley Securities Consumer & TMT Conference on September 10th at the Sofitel, New York.

Axcelis Technologies (Nasdaq: ACLS) has announced a strategic Joint Development Program (JDP) with GE Aerospace to develop production-worthy 6.5 to 10kV superjunction power devices. The collaboration will utilize Axcelis' Purion XEmax™ high energy implanter, which offers the industry's highest beam currents up to 15MeV.

The partnership is part of the Commercial Leap Ahead for Wide Bandgap Semiconductors (CLAWS) Hub project led by North Carolina State University. The initiative focuses on developing Silicon Carbide (SiC) wide bandgap semiconductors, which offer superior performance in voltage, operating temperatures, and frequencies compared to traditional Silicon devices. These advanced semiconductors are crucial for aerospace, defense, AI, quantum computing, autonomous vehicles, and power grid applications.

Axcelis Technologies (NASDAQ: ACLS) reported its Q2 2025 financial results with revenue of $194.5 million, showing resilience despite market challenges. The company achieved a GAAP gross margin of 44.9% and non-GAAP gross margin of 45.2%, with GAAP diluted EPS of $0.98 and non-GAAP EPS of $1.13.

Notable highlights include increased share repurchase activity of $45 million during the quarter and strong profitability despite cyclical market digestion. For Q3 2025, Axcelis projects revenues of approximately $200 million with GAAP EPS of $0.87 and non-GAAP EPS of $1.00.

Axcelis Technologies (NASDAQ: ACLS), a leading provider of ion implantation solutions for the semiconductor industry, has announced its participation in three upcoming investor conferences in August 2025:

• KBCM Technology Leadership Forum - August 11th at Montage Deer Valley, Park City, UT
• Jefferies Semiconductor, IT Hardware and Communications Technology Conference - August 26th at Four Seasons Hotel, Chicago, IL
• Evercore ISI 2025 Semiconductor Conference - August 27th at Omni Chicago, IL

Axcelis Technologies (Nasdaq: ACLS), a leading semiconductor ion implantation solutions provider, has scheduled its Q2 2025 earnings release and conference call. The financial results will be released before market open on Tuesday, August 5, 2025, followed by a conference call at 8:30 a.m. ET the same day.

Investors can access the webcast through Axcelis' website investor section or by registering directly through the provided link. The webcast replay will remain available for 30 days after the call.

Axcelis Technologies (NASDAQ: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has announced its participation in eight major investor conferences between May and June 2025. The company will attend prestigious events including the J.P. Morgan Global Technology Conference, B. Riley Investor Conference, TD Cowen Technology Conference, Stifel Cross Sector Conference, William Blair Growth Stock Conference, Bank of America Global Technology Conference, and DA Davidson Consumer & Technology Conference.

At the William Blair conference, management will conduct a Fireside Chat at 2:00 PM Central Time on June 4th, which will be publicly accessible via webcast through Axcelis' website.